A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of tazarotene Lotion and tazarotene Vehicle Lotion in the Treatment of Acne Vulgaris

Trial Profile

A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of tazarotene Lotion and tazarotene Vehicle Lotion in the Treatment of Acne Vulgaris

Recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Sep 2017

At a glance

  • Drugs Tazarotene
  • Indications Acne vulgaris
  • Focus Registrational; Therapeutic Use
  • Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
  • Most Recent Events

    • 15 Sep 2017 Status changed from not yet recruiting to recruiting.
    • 27 Jul 2017 According to Valeant Pharmaceuticals International media release, Valeant Pharmaceuticals International renamed its dermatolgy unit as Ortho Dermatologics.
    • 12 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top